You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RSV A Memphis 37

Showing 1 - 25 of 1,948
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Syncytial Virus Trial in London (Molnupiravir, Placebo, RSV A Memphis 37b)

Recruiting
  • Respiratory Syncytial Virus
  • London, London, City Of, United Kingdom
    hVIVO Services ( Site 0001)
Feb 2, 2023

Respiratory Syncytial Viruses Trial in London (MK-1654, Placebo, RSV-A Memphis 37b)

Completed
Has Results
  • Respiratory Syncytial Viruses
  • Clesrovimab
  • +2 more
  • London, United Kingdom
    HVIVO Services Ltd ( Site 0001)
Aug 29, 2022

Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)

Terminated
  • Respiratory Syncytial Virus Infections
  • Influenza, Human
  • RSV A Memphis 37
  • Influenza A/California/04/2009
  • London, United Kingdom
    National Heart and Lung Institute, Imperial College London
Jun 23, 2022

Healthy Adult Participants Trial in London (Palivizumab, Placebo, RSV-A Memphis 37b virus)

Completed
Has Results
  • Healthy Adult Participants
  • London, United Kingdom
    hVIVO Services Limited
Sep 7, 2021

Respiratory Syncytial Virus (RSV) Trial in London (RV299, Placebo)

Completed
  • Respiratory Syncytial Virus (RSV)
  • London, United Kingdom
    Pfizer
Oct 5, 2023

RSV Infection Trial in London (MVA-mBN294B, Placebo)

Completed
  • RSV Infection
  • MVA-mBN294B
  • Placebo
  • London, United Kingdom
    hVIVO Services Limited
Mar 31, 2022

Respiratory Syncytial Virus Infections Trial in United States (D46/NS2/N/?M2-2-HindIII, Placebo)

Completed
Has Results
  • Respiratory Syncytial Virus Infections
  • D46/NS2/N/ΔM2-2-HindIII
  • Placebo
  • Los Angeles, California
  • +9 more
Jan 13, 2022

RSV Infection Trial in London (Challenge virus RSV-A Memphis 37b)

Completed
  • RSV Infection
  • Challenge virus RSV-A Memphis 37b
  • London, United Kingdom
    hVIVO Services Limited
Oct 10, 2019

RSV Infection Trial in London (RSV A Memphis 37)

Recruiting
  • RSV Infection
  • RSV A Memphis 37
  • London, United Kingdom
    Imperial College London
Aug 13, 2019

Respiratory Syncytial Virus (RSV) Trial in Worldwide (EDP-938, Placebo)

Recruiting
  • Respiratory Syncytial Virus (RSV)
  • Long Beach, California
  • +62 more
Oct 9, 2022

RSV Infection Trial in London (EDP-938 Dose 1, EDP-938 Dose 2, Placebo)

Completed
Has Results
  • RSV Infection
  • EDP-938 Dose 1
  • +4 more
  • London, United Kingdom
    hVIVO Services Limited (hVIVO)
Apr 6, 2022

Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, FLU vaccine)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • FLU vaccine
  • Edegem, Belgium
  • +33 more
Dec 7, 2022

Respiratory Syncytial Virus Infections Trial in Canada, Sweden, United States (RSVPreF3 OA investigational vaccine)

Completed
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA investigational vaccine
  • Waterbury, Connecticut
  • +19 more
Aug 5, 2022

Respiratory Tract Infections Trial in Worldwide (Rilematovir, Rilematovir X mg/kg, Placebo)

Terminated
  • Respiratory Tract Infections
  • Orlando, Florida
  • +142 more
Apr 11, 2022

Respiratory Syncytial Virus Trial in Worldwide (mRNA-1345, Placebo)

Recruiting
  • Respiratory Syncytial Virus
  • mRNA-1345
  • Placebo
  • Birmingham, Alabama
  • +61 more
Nov 19, 2023

Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345)

Recruiting
  • Respiratory Syncytial Virus
  • Birmingham, Alabama
  • +269 more
Jan 30, 2023

Respiratory Viral Infections in Pediatric Transplant Recipients

Recruiting
  • Hematopoietic Cell Transplant
  • +2 more
    • Little Rock, Arkansas
    • +4 more
    Jan 11, 2023

    Respiratory Syncytial Virus Infections Trial in United States (RSVPreF3 OA investigational vaccine, FLU HD vaccine)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 OA investigational vaccine
    • FLU HD vaccine
    • Birmingham, Alabama
    • +46 more
    Jan 12, 2023

    RSV Infection Trial in Worldwide (Nirsevimab)

    Active, not recruiting
    • RSV Infection
    • Los Angeles, California
    • +27 more
    Mar 18, 2022

    Respiratory Tract Infections Trial in United States (Formulation A, Formulation B, Placebo)

    Completed
    Has Results
    • Respiratory Tract Infections
    • Formulation A
    • +2 more
    • Mobile, Alabama
    • +39 more
    Mar 1, 2022

    Respiratory Tract Infection Trial in Worldwide (RSV vaccine, Placebo)

    Completed
    Has Results
    • Respiratory Tract Infection
    • RSV vaccine
    • Placebo
    • Birmingham, Alabama
    • +158 more
    Sep 20, 2022

    Respiratory Syncytial Virus Infections Trial (RSVPreF3 vaccine, Control)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • RSVPreF3 vaccine
    • Control
    • (no location specified)
    Jan 20, 2023

    Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Placebo)

    Active, not recruiting
    • Respiratory Syncytial Virus Infections
    • Birmingham, Alabama
    • +214 more
    Feb 4, 2022

    Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)

    Recruiting
    • Respiratory Syncytial Virus Infections
    • RSV ΔNS2 Δ1313 I1314L Vaccine
    • Placebo
    • Baltimore, Maryland
    • +1 more
    Dec 2, 2022

    National Observatory of Children Hospitalized for Bronchiolitis

    Active, not recruiting
    • Bronchiolitis
      • Créteil, France
        ACTIV
      Oct 27, 2023